Diabetic cardiovascular autonomic neuropathy: prognosis, diagnosis and treatment. (Q40553843)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7796704%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

review article

1 reference

title

Diabetic cardiovascular autonomic neuropathy: prognosis, diagnosis and treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7796704%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference

Ziegler D

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7796704%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

publication date

1 December 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7796704%20AND%20SRC:MED&resulttype=core&format=json

Diabetes/metabolism reviews

26 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7796704%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7796704%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7796704%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

page(s)

339-383

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7796704%20AND%20SRC:MED&resulttype=core&format=json

Consensus statement: Report and recommendations of the San Antonio conference on diabetic neuropathy. American Diabetes Association American Academy of Neurology

26 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Diabetic autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Diabetic autonomic neuropathy: present insights and future prospects

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Diagnosis and management of diabetic autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Diabetic autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Heart rate variability

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Diabetic neuropathies

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Clinical observations and experiments in diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Sympathetic nerve failure in diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Cardiac denervation in diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

The epidemiology of diabetic neuropathy. Diabetic Cardiovascular Autonomic Neuropathy Multicenter Study Group

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Influence of pancreas transplantation on cardiorespiratory reflexes, nerve conduction, and mortality in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Mortality in diabetic patients with cardiovascular autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Mortality and treatment side-effects during long-term intensified conventional insulin treatment in the Stockholm Diabetes Intervention Study

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Heart rate variability in patients with diabetes mellitus, ischemic heart disease, and congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Heart rate variability and baroreflex sensitivity in myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Acute myocardial infarction in the diabetic patient: pathophysiology, clinical course and prognosis

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Natural history of autonomic neuropathy in chronic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Mortality in alcoholics with autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

QT prolongation and sudden cardiac death in patients with alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Cardiorespiratory arrest and diabetic autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Prolonged QT period in diabetic autonomic neuropathy: a possible role in sudden cardiac death?

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

QT prolongation on the electrocardiogram in diabetic autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

QT interval length and diabetic autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Corrected Q-T interval prolongation as diagnostic tool for assessment of cardiac autonomic neuropathy in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

QT interval prolongation in type 2 (non-insulin-dependent) diabetic patients with cardiac autonomic neuropathy.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

QT interval prolongation and sudden cardiac death in diabetic autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Prevalence of QT prolongation in a type 1 diabetic population and its association with autonomic neuropathy. The Neuropathy Study Group of the Italian Society for the Study of Diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

The role of the autonomic nervous system in sudden coronary death

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Neural Activity and Ventricular Fibrillation

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Heart rate variability from 24-hour electrocardiography and the 2-year risk for sudden death

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Sleep apnoea in diabetic patients with autonomic neuropathy.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Breathing, sleep, and diabetic autonomic neuropathy.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Autonomic neuropathy and the ventilatory responses of diabetics to progressive hypoxemia and hypercarbia

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Impaired hypoxic ventilatory drive in diabetic patients with autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

No effect of naloxone on ventilatory response to progressive hypercapnia in IDDM patients

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Respiratory responses of diabetics to hypoxia, hypercapnia, and exercise

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Chemosensitivity in patients with diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Polyols and myo-inositol in diabetic neuropathy--of mice and men

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Aldose reductase inhibitors and the complications of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Complications: neuropathy, pathogenetic considerations

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Pathogenesis of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Pathogenesis of diabetic neuropathy: the role of the n-6 essential fatty acids and their eicosanoid derivatives

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Cause and effect of ischaemia in chronic experimental diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

The role of nerve growth factor in the pathogenesis and therapy of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Hypoxic neuropathy: does hypoxia play a role in diabetic neuropathy? The 1988 Robert Wartenberg lecture

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Potential therapeutic approaches to the treatment or prevention of diabetic neuropathy: evidence from experimental studies

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Effect of Aminoguanidine on Functional and Structural Abnormalities in Peripheral Nerve of STZ-Induced Diabetic Rats

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Diabetes mellitus-associated decrease in nerve growth factor levels is reversed by allogeneic pancreatic islet transplantation

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Aggregation of Subclinical Autonomic Nervous System Dysfunction and Autoantibodies in Families With Type I Diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Anti-sympathetic nervous system autoantibodies. Diminished catecholamines with orthostasis.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Anti-adrenal medullary antibodies in IDDM subjects and subjects at high risk of developing IDDM

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Diabetes and autonomic neuropathy: an immunological association?

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Cell-mediated immunity and symptomatic diabetic autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Diabetic autonomic neuropathy and iritis: an association suggesting an immunological cause.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Complement-Fixing Antibodies to Sympathetic and Parasympathetic Tissuesin IDDM: Autonomic Brake Index and Heart-Rate Variation

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Anti-sympathetic ganglia antibodies and postural blood pressure in IDDM subjects of varying duration and patients at high risk of developing IDDM.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Uveitis and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Autonomic nerve antibodies and autonomic nerve function in type 1 and type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Autoantibodies to nervous tissue structures are associated with autonomic neuropathy in type 1 (insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Glutamic acid decarboxylase antibodies, autonomic nerve antibodies and autonomic neuropathy in diabetic patients

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Multiple immunological abnormalities in patients with type 1 (insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Risk for cardiovascular autonomic neuropathy is associated with the HLA-DR3/4 phenotype in type I diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

The sympathetic chain in patients with diabetic and alcoholic polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Myelinated fibres in human paravertebral sympathetic chain: white rami communicantes in alcoholic and diabetic patients

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Changes in the sympathetic nervous system in diabetes mellitus. A preliminary report

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

The sympathetic nervous system in diabetic neuropathy. A clinical and pathological study.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Pathology of Autonomic Neuropathy in Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

A morphometric study of the carotid sinus nerve in patients with diabetes mellitus and chronic alcoholism

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Fine structure of presynaptic axonal terminals in sympathetic autonomic ganglia of aging and diabetic human subjects

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Autonomic neuropathy and painless myocardial infarction in diabetic patients. Histologic evidence of their relationship

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Pathology of the autonomic nerve innervating the vasa nervorum in diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Heart rate changes in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Abnormalities of ambulatory 24-hour heart rate in diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Beat-to-beat variation of heart rate in diabetic patients with autonomic neuropathy and in completely cardiac denervated patients following orthotopic heart transplantation

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Spectral analysis of heart rate variability following human heart transplantation: evidence for functional reinnervation

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Evidence for regional catecholamine uptake and storage sites in the transplanted human heart by positron emission tomography

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Assessment of cardiovascular autonomic function: age-related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Cardiovascular effects of therapeutic doses of tricyclic antidepressants. A review

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Differential effects of amitriptyline on sudomotor, cardiovagal, and adrenergic function in human subjects

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Provocation of postural hypotension by insulin in diabetic autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Mechanisms of arterial hypotension after therapeutic dose of subcutaneous insulin in diabetic autonomic neuropathy.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Effects of hyperinsulinaemia on the cardiovascular responses to graded hypovolaemia in normal and diabetic subjects.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Hemodynamics in diabetic orthostatic hypotension

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Baroreflex control of plasma norepinephrine and heart period in healthy subjects and diabetic patients

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Plasma adrenaline and noradrenaline concentrations in diabetic patients with and without autonomic neuropathy at rest and during sympathetic stimulation

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Plasma catecholamines in diabetes. The syndromes of hypoadrenergic and hyperadrenergic postural hypotension

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

The pathogenesis of hyperadrenergic postural hypotension in diabetic patients

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Norepinephrine secretion and production in diabetic autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Plasma Catecholamines in Long-Term Diabetics with and without Neuropathy and in Hypophysectomized Subjects

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Catecholamines and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Noradrenaline and isoproterenol kinetics in diabetic patients with and without autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Vascular responses in diabetic peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Responsiveness of superficial hand veins to alpha-adrenoceptor agonists in insulin-dependent diabetic patients

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Metabolic and cardiovascular responses to epinephrine in diabetic autonomic neuropathy.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Plasma adrenaline kinetics in type 1 (insulin-dependent) diabetic patients with and without autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Adrenergic receptors are a fallible index of adrenergic denervation hypersensitivity

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Decreased alpha 2-adrenergic receptors on platelet membranes from diabetic patients with autonomic neuropathy and orthostatic hypotension

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Decreased high affinity state in platelet alpha 2-adrenoceptors from diabetic patients with orthostatic hypotension

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Increased lipolytic sensitivity to catecholamines in diabetic patients with severe autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Control of heart rate by the autonomic nervous system. Studies in man on the interrelation between baroreceptor mechanisms and exercise

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Impaired Cardiovascular Responses to Graded Exercise in Diabetic Autonomic Neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Decreased exercise heart rate and blood pressure response in diabetic subjects with cardiac autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Haemodynamic changes during graded exercise in patients with diabetic autonomic neuropathy.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Abnormal cardiac function in diabetic patients with autonomic neuropathy in the absence of ischemic heart disease

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Autonomic influence on cardiovascular performance in diabetic subjects

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Radionuclide assessment of left ventricular diastolic filling in diabetes mellitus with and without cardiac autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Impairment of diastolic function in middle-aged type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients free of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Augmentation of Atrial Contribution to Left Ventricular Filling in IDDM Subjects as Assessed by Doppler Echocardiography

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Anatomical and functional cardiac abnormalities in type I diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Autonomic nervous function and its relationship to cardiac performance in middle-aged diabetic patients without clinically evident cardiovascular disease

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Left ventricular function and dimensions in newly diagnosed non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Diabetic heart disease: the clinical and pathological spectrum--Part I.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Diabetic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Diabetic heart muscle disease

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Factors that influence outcome in diabetic subjects with myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Association Between Silent Coronary Artery Disease, Diabetes, and Autonomic Neuropathy: Fact or Fallacy?

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Effect of Coronary Artery Disease on Parasympathetic Cardiovascular Reflexes in NIDDM Patients

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Clinical features of unrecognized myocardial infarction--silent and symptomatic. Eighteen year follow-up: the Framingham study

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Silent myocardial infarction and diabetic cardiovascular autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Exertional myocardial ischemia in diabetes: a quantitative analysis of anginal perceptual threshold and the influence of autonomic function

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Prolonged anginal perceptual threshold in diabetes: effects on exercise capacity and myocardial ischemia

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

The perception of angina in diabetes: relation to somatic pain threshold and autonomic function

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Usefulness of plasma beta-endorphin level, pain threshold and autonomic function in assessing silent myocardial ischemia in patients with and without diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Detection of silent myocardial ischemia in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Autonomic dysfunction and silent myocardial ischaemia on exercise testing in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Asymptomatic myocardial ischemia in diabetes and its relationship to diabetic neuropathy: an exercise electrocardiography study in middle-aged diabetic men

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Asymptomatic transient ST changes during ambulatory ECG monitoring in diabetic patients

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Silent ischaemia in diabetic men with autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Asymptomatic myocardial ischemia during percutaneous transluminal coronary angioplasty and importance of prior Q-wave infarction and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Silent myocardial ischemia: role of subclinical neuropathy in patients with and without diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Diabetes and anaesthesia: the past decade

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Increased intraoperative cardiovascular morbidity in diabetics with autonomic neuropathy.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Diabetic autonomic neuropathy: abnormal cardiovascular reactions under general anesthesia.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Epinephrine secretion, hypoglycemia unawareness, and diabetic autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Adrenomedullary hypofunction and diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Iatrogenic hypoglycemia as a cause of hypoglycemia-associated autonomic failure in IDDM. A vicious cycle

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Hypoglycemia begets hypoglycemia in IDDM.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Plasma endothelin during upright tilt: relevance for orthostatic hypotension?

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Plasma endothelin in diabetic autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Vasopressin secretion in diabetic subjects with and without autonomic neuropathy: responses to osmotic and postural stimulation

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Vasopressin response to orthostatic hypotension. Etiologic and clinical implications

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

The activity of the renin-angiotensin-aldosterone system before and during submaximal bicycle exercise in relation to circulatory catecholamines in patients with type 1 (insulin-dependent) diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Antidiuretic hormone response to volume depletion in diabetic patients with cardiac autonomic dysfunction

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Increased plasma atrial natriuretic factor and reduced plasma renin in patients with poorly controlled diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Regulation of ANP secretion in insulin-dependent diabetes mellitus and the influence of autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Does mild autonomic neuropathy affect atrial natriuretic factor regulation in diabetic hypertensive patients?

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Decreased response of plasma renin activity to orthostasis in diabetic patients with orthostatic hypotension

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Impaired responses of catecholamines, growth hormone, and cortisol to graded exercise in diabetic autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Exercise and posture-related changes of atrial natriuretic factor and cardiac function in diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Possible involvement of hypersecretion of ADH in hyponatremia in a diabetic patient complicated with severe neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Plasma renin activity in diabetic autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Hormonal, Metabolic, and Cardiovascular Responses to Hypoglycemia in Diabetic Autonomic Neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Reduced epinephrine secretion and hypoglycemia unawareness in diabetic autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Unawareness of hypoglycaemia and inadequate hypoglycaemic counterregulation: no causal relation with diabetic autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Unawareness of hypoglycaemia in insulin-treated diabetic patients: prevalence and relationship to autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

The adrenal medullary response to hypoglycemia in patients with orthostatic hypotension

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Physiological, symptomatic and hormonal responses to acute hypoglycaemia in type 1 diabetic patients with autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Can insulin-treated diabetics be given beta-adrenergic-blocking drugs?

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Can insulin-treated diabetics be given beta-adrenergic blocking drugs?

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Higher Glycemic Thresholds for Symptoms During β-Adrenergic Blockade in IDDM

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Which battery of cardiovascular autonomic function tests?

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

The assessment of cardiovascular reflex activity: standardization is needed.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Physiological and clinical correlates of cardiorespiratory reflexes in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Prevalence of cardiovascular autonomic dysfunction assessed by spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses at various stages of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Heart rate variability in healthy subjects: effect of age and the derivation of normal ranges for tests of autonomic function

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Which battery of cardiovascular autonomic function tests--suggestion for a rational diagnostic model

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Cardiac Denervation in Diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Assessment of vagal control of the heart in diabetes. Measures of R-R interval variation under different conditions

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Cardiac autonomic neuropathy in diabetes: comparison of measures of R-R interval variation

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Heart Rate Variability in Healthy Subjects Measured with a Bedside Computer-Based Technique

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Respiratory influence on heart rate in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

An improved method for measuring heart-rate variability: assessment of cardiac autonomic function.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

RR interval variations in young male diabetics

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

A long-term diabetic autonomic nervous abnormality. Reduced variations in resting heart rate measured by a simple and sensitive method

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Use of runs test to assess cardiovascular autonomic function in diabetic subjects

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Immediate heart-rate response to standing: simple test for autonomic neuropathy in diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

A simple test of cardiac function based upon the heart rate changes induced by the Valsalva maneuver

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Autonomic control of the immediate heart rate response to lying down.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Cough test to assess cardiovascular autonomic reflexes in diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Mental arithmetic stress as a test for evaluation of diabetic sympathetic autonomic neuropathy.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Assessment of methods for estimating autonomic nervous control of the heart in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Abnormal diastolic blood pressure and heart rate reactions to tilting in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

The squatting test. A useful tool to assess both parasympathetic and sympathetic involvement of the cardiovascular autonomic neuropathy in diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Vascular reflexes in diabetic autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Cardiovascular responses to tilting in healthy and diabetic subjects

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Detection of early sympathetic cardiovascular neuropathy by squatting test in NIDDM

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Respiratory sinus arrhythmia in diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

The value of cardiovascular autonomic function tests: 10 years experience in diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Determining heart-rate variability: comparing methodologies using computer simulations

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Computerized simultaneous determination of natural age groups for 32 baroreflex arc function parameters and of the corresponding normal ranges for use in the diagnosis of cardiovascular autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Cardiovascular autonomic reflex tests: normal responses and age-related reference values

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Diabetic autonomic neuropathy--Part I. Autonomic nervous system data analysis by a computerized central unit in a multicenter trial

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Diabetic autonomic neuropathy--Part II. Coefficient of variation of RR-variation and Valsalva maneuver tests.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Reduced sinus arrhythmia in diabetic autonomic neuropathy: diagnostic value of an age-related normal range.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Automatic analysis of heart rate variation: I. Method and reference values in healthy controls

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Automatic analysis of heart rate variation: II. Findings in patients attending an EMG laboratory

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Reflex control of heart rate in normal subjects in relation to age: a data base for cardiac vagal neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Autonomic nerve function tests. Reference values in healthy subjects

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Autonomic function tests as related to age and gender in normal man

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Autonomic function testing in diabetic subjects using sequential measurements

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Repeatability of measurements and sources of variability in tests of cardiovascular autonomic function

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Reproducibility of parameters for assessment of diabetic neuropathy. The French Group for Research and Study of Diabetic Neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

An automated computerized method using Finapres for measuring cardiovascular reflexes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

An efficient algorithm for spectral analysis of heart rate variability

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Spectral analysis of heart rate variability in the assessment of autonomic diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Analysis of heart rate variability

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Spectral analysis of heart rate fluctuations. A non-invasive, sensitive method for the early diagnosis of autonomic neuropathy in diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Heart rate variability in diabetic patients during orthostatic load--a spectral analytic approach

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Heart rate fluctuations in diabetic patients with cardiac vagal dysfunction: a spectral analysis

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Sampling frequency of the electrocardiogram for spectral analysis of the heart rate variability.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Spectral analysis of spontaneous heart rate variation in diabetic patients

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Spectral analysis of heart rate in diabetic autonomic neuropathy. A comparison with standard tests of autonomic function

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Spectral analysis of heart rate variability signal and respiration in diabetic subjects.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Power spectral analysis of the electrocardiogram in diabetic children

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Power spectral analysis of heart-rate variations improves assessment of diabetic cardiac autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Cross correlation of heart rate and respiration versus deep breathing. Assessment of new test of cardiac autonomic function in diabetes.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Usefulness of cardiovascular tests of autonomic function in asymptomatic diabetic patients

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Circadian variation and triggers of onset of acute cardiovascular disease

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Continuous 24-hour assessment of the neural regulation of systemic arterial pressure and RR variabilities in ambulant subjects

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Circadian variation of blood-pressure

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

New method for assessing cardiac parasympathetic activity using 24 hour electrocardiograms

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Twenty four hour heart rate variability: effects of posture, sleep, and time of day in healthy controls and comparison with bedside tests of autonomic function in diabetic patients

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Circadian variation of heart rate variability

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Heart-rate variability and cardiac autonomic function in diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Association of 24-h Cardiac Parasympathetic Activity and Degree of Nephropathy in IDDM Patients

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Impaired circadian modulation of sympathovagal activity in diabetes. A possible explanation for altered temporal onset of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Relationship between the circadian rhythms of blood pressure and sympathovagal balance in diabetic autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Differing circadian patterns of symptom onset in subgroups of patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Diabetic autonomic dysfunction, blood pressure, and sleep.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Ambulatory blood pressure and heart rate in diabetic patients: an assessment of autonomic function

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Circadian rhythm of blood pressure in normotensive NIDDM subjects. Its relationship to microvascular complications.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Twenty-four Hour Blood Pressure and Heart Rate Profiles of Diabetic Patients with Abnormal Cardiovascular Reflexes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Loss of nocturnal decline in blood pressure after cardiac transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Day and night variation in ambulatory blood pressure in type 1 diabetes mellitus with nephropathy and autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Circadian variation of blood pressure in autonomic failure

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Diurnal variation of the QT interval--influence of the autonomic nervous system

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Long QT syndrome with insulin-dependent diabetes mellitus: contiguous gene syndrome on chromosome 11p

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

The values and limitations of the QT interval in clinical practice

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study)

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Circadian rhythmicity of heart rate and QTc interval in diabetic autonomic neuropathy: implications for the mechanism of sudden death

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Is the corrected QT interval a reliable indicator of the severity of diabetic autonomic neuropathy?

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Information on type 1 diabetes mellitus and QT interval from identical twins

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Imaging of metabolism and autonomic innervation of the heart by positron emission tomography.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Noninvasive detection of cardiac sympathetic nervous dysfunction in diabetic patients using [123I]metaiodobenzylguanidine

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Noninvasive assessment of cardiac diabetic neuropathy by carbon-11 hydroxyephedrine and positron emission tomography

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Heart rate variability in diabetes: relationship to age and duration of the disease

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Differential changes of autonomic nervous system function with age in man.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Diabetic autonomic neuropathy and cardiovascular risk. Pittsburgh Epidemiology of Diabetes Complications Study III

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Body Fat and the Activity of the Autonomic Nervous System

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Autonomic neuropathy in non-insulin dependent (type II) diabetes mellitus. Possible influence of obesity

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Impaired Cardiac Adjustment to Pregnancy in Type I Diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Effect of Pregnancy on Autonomic Nervous Function and Heart Rate in Diabetic and Nondiabetic Women

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Pregnancy is Not a Risk Factor for a Deterioration of Autonomic Nervous Function in Diabetic Women

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Autonomic neuropathy in pregnancy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Autonomic influence on pregnancy outcome in IDDM.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Autonomic and electrophysiological studies in patients with signs or symptoms of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Peripheral motor nerve function in diabetic autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Autonomic disturbances in relation to sensorimotor peripheral neuropathy in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Development of a predictive model for symptomatic neuropathy in diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Lawrence lecture. The diabetic foot: neuropathic in aetiology?

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Autonomic function in neuropathic diabetic patients with foot ulceration

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Lower limb arterio-venous shunts, autonomic neuropathy and diabetic foot

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Abnormal Thermoregulation in Diabetic Autonomic Neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Muscle sympathetic nerve activity is reduced in IDDM before overt autonomic neuropathy.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

No reason to regard a low number of bursts of muscle sympathetic nerve activity in IDDM as a sign of autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Risk of Early-Onset Proliferative Retinopathy in IDDM Is Closely Related to Cardiovascular Autonomic Neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Importance of cardiovascular autonomic dysfunction in IDDM subjects with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

The relationship between autonomic neuropathy and urinary sodium and albumin excretion in insulin-treated diabetics

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Autonomic neuropathy predicts deterioration in glomerular filtration rate in patients with IDDM.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Short-term heart rate variability and factors modifying the risk of coronary artery disease in a population sample

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Effect of atenolol and diltiazem on heart period variability in normal persons

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Effects of digoxin and enalapril on heart period variability and response to head-up tilt in normal subjects

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Effects of metoprolol on heart rate variability in survivors of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Heart rate variability in patients with ventricular arrhythmias: effect of antiarrhythmic drugs. Antiarrhythmic Drug Evaluation Group (ADEG).

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Diabetic autonomic neuropathy: the prevalence of impaired heart rate variability in a geographically defined population

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Prevalence of neuropathy in newly diagnosed NIDDM and nondiabetic control subjects.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Prevalence of peripheral and autonomic neuropathy in newly diagnosed type II (noninsulin-dependent) diabetes.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Prevalence of cardiovascular autonomic dysfunction assessed by spectral analysis and standard tests of heart-rate variation in newly diagnosed IDDM patients

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

The natural history of somatosensory and autonomic nerve dysfunction in relation to glycaemic control during the first 5 years after diagnosis of type 1 (insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Progression of subclinical polyneuropathy in young patients with type 1 (insulin-dependent) diabetes: associations with glycaemic control and microangiopathy (microvascular complications)

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Natural history of the diabetic neuropathies

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Autonomic neuropathy in diabetes mellitus: a follow-up study

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Does improved control of glycemia prevent or ameliorate diabetic polyneuropathy? Committee on Health Care Issues, American Neurological Association

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Blood glucose control and diabetic microvascular complications: long-term effects of near-normoglycaemia

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Lessons from the Diabetes Control and Complications Trial

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Peripheral and autonomic nerve function in diabetic ketoacidosis

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Letter: Autonomic dysfunction in diabetic ketoacidosis

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Letter: Acute autonomic dysfunction in diabetic ketoacidosis

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Peripheral and autonomic nerve function in newly diagnosed diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Autonomic and somatosensory nerve function after 2 years of continuous subcutaneous insulin infusion in type I diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 years

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Differential effects of near-normoglycaemia for 4 years on somatic nerve dysfunction and heart rate variation in type 1 diabetic patients

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Is pancreas transplantation for insulin-dependent diabetics worthwhile?

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Effects of Pancreatic Transplantation on Diabetic Neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Fate of late complications in type I diabetic patients after successful pancreas-kidney transplantation

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Improvement of Nerve Conduction in Diabetic Neuropathy: A Follow-up Study 4 Yr After Combined Pancreatic and Renal Transplantation

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Effect of metabolic control on autonomic function in obese patients with newly diagnosed type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Aldose reductase inhibitors in the treatment of diabetic neuropathy. A review of the rationale and clinical evidence

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Clinical and neurophysiological studies with the aldose reductase inhibitor, sorbinil, in symptomatic diabetic neuropathy.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Limited benefit of treatment of diabetic polyneuropathy with an aldose reductase inhibitor: a 24-week controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Six-month treatment with sorbinil in asymptomatic diabetic neuropathy. Failure to improve abnormal nerve function

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Diabetic neuropathy in the upper limb and the effect of twelve months sorbinil treatment

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Aldose reductase inhibition in diabetic neuropathy: clinical and neurophysiological studies of one year's treatment with sorbinil

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

One-year treatment with the aldose reductase inhibitor, ponalrestat, in diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

A 12-Month Randomized Controlled Study of the Aldose Reductase Inhibitor Ponalrestat in Patients with Chronic Symptomatic Diabetic Neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Treatment of diabetic autonomic neuropathy with an aldose reductase inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Effects of ponalrestat, an aldose reductase inhibitor, on neutrophil killing of Escherichia coli and autonomic function in patients with diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Tolrestat for Mild Diabetic Neuropathy: A 52-Week, Randomized, Placebo-Controlled Trial

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Influence of long-term aldose reductase inhibitor therapy on autonomic dysfunction of urinary bladder, stomach and cardiovascular systems in diabetic patients

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

The effect of an aldose reductase inhibitor on cardiovascular performance in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Clinical experience with sorbinil--an aldose reductase inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

The use of gamma linolenic acid in the prevention and treatment of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Treatment of diabetic neuropathy with gamma-linolenic acid. The gamma-Linolenic Acid Multicenter Trial Group

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Beneficial effect of Org 2766 in treatment of peripheral neuropathy in streptozocin-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Randomized double-blind placebo-controlled trial to evaluate the effect of the ACTH4-9 analogue ORG 2766 in IDDM patients with neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Enhancement of peripheral nerve regeneration

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Clinical uses of gangliosides in diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

A Double Blind Placebo Controlled Trial of Mixed Gangliosides in Diabetic Peripheral and Autonomic Neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Effect of gangliosides on diabetic peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Guillain-Barré syndrome after exogenous gangliosides in Italy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Physical manoeuvres for combating orthostatic dizziness in autonomic failure

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

9-Alpha-Fluorohydrocortisone in the Treatment of Postural Hypotension in Diabetic Autonomic Neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Therapeutic experience with fludrocortisone in diabetic postural hypotension

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Treatment of orthostatic hypotension with dihydroergotamine and caffeine.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Treatment of orthostatic hypotension with erythropoietin

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Treatment of autonomic neuropathy with a somatostatin analogue SMS-201-995

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Hemodynamic effects of octreotide in patients with autonomic neuropathy.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Treatment of diabetic orthostatic hypotension with pindolol

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Effects of beta adrenergic receptor agonists and antagonists in diabetics with symptoms of postural hypotension: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Metoclopramide alone or combined with flurbiprofen in the treatment of orthostatic hypotension associated with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Diltiazem for tachycardiac orthostatic hypotension in NIDDM

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100403

7 January 2021

Identifiers

DOI

10.1002/DMR.5610100403

0 references

1 reference